Primäre Lebertumoren im Kindesalter

D. G. Schreiber-Dietrich; I. Leuschner; A. Tannapfel; D. Franke; M. Stenzel; J. Juengert; C. F. Dietrich

doi:10.1055/s-0042-107993

TumorDiagnostik & Therapie, Table of Contents

TumorDiagnostik & Therapie 2016; 37(05): 272-280
DOI: 10.1055/s-0042-107993

Thieme Onkologie aktuell

Primäre Lebertumoren im Kindesalter

Primary liver tumours in childhood

D. G. Schreiber-Dietrich

¹Pädiatrie, Caritas-Krankenhaus, Bad Mergentheim, Germany

,

I. Leuschner

²Kindertumorregister, Pathologie, Kiel, Germany

,

A. Tannapfel

³Pathologie, Ruhruniversität, Bochum, Germany

,

D. Franke

⁴Pädiatrie, MHH, Hannover, Germany

,

M. Stenzel

⁵Radiologie, Universitätsklinikum Freiburg, Germany

,

J. Juengert

⁶Kinderklinik, Universität Erlangen, Germany

,

C. F. Dietrich

⁷Innere Medizin 2, Caritas Krankenhaus Bad Mergentheim, Germany

› Author Affiliations

Abstract

Zusammenfassung

Die Prävalenz von Lebertumoren ist im Erwachsenenalter und bei Kindern unterschiedlich. Ziel dieser Arbeit ist es, die Besonderheiten von Lebertumoren im Säuglings- und Kindesalter unter histopathologischen Überlegungen herauszuarbeiten und die Möglichkeiten der Kontrastmittelsonografie zu diskutieren. Ziel dieses Artikels ist es auch, auf die Datensammlung der European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) aufmerksam zu machen („Pediatric Registry“, www.efsumb.org), die die Anwendungsmöglichkeiten und Sicherheit der Kontrastmittelsonografie im Kindesalter dokumentieren soll.

Abstract

The reported prevalence of focal liver lesions in adult patients and children is different. The article discusses pediatric liver tumors under the criteria of histopathology and contrast enhanced ultrasound (CEUS) features. Aim of this article is also to support the already established Pediatric Registry of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) to collect data on safety and applications of ultrasound contrast agents in children (www.efsumb.org).

Schlüsselwörter

Richtlinien - bildgebende Diagnostik - Hämangiom

Key words

guideline - imaging - hemangioma

Full Text

References

Literatur
1 Schreiber-Dietrich D, Dietrich CF. Contrast enhanced ultrasound (CEUS) and off-label use (in children). Ultraschall in Med 2012; 33: 295-296
2 Schreiber-Dietrich DG, Cui XW, Piscaglia F et al. Contrast enhanced ultrasound in pediatric patients: a real challenge. Z Gastroenterol 2014; 52: 1178-1184
3 Seitz K, Strobel D, Bernatik T et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions – prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall in Med 2009; 30: 383-389
4 Strobel D, Seitz K, Blank W et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions – diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall in Med 2008; 29: 499-505
5 Strobel D, Bernatik T, Blank W et al. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall in Med 2011; 32: 593-597
6 Seitz K, Greis C, Schuler A et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall in Med 2011; 32: 598-603
7 Strobel D, Seitz K, Blank W et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall in Med 2009; 30: 376-382
8 Bernatik T, Seitz K, Blank W et al. Unclear focal liver lesions in contrast-enhanced ultrasonography – lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall in Med 2010; 31: 577-581
9 Piscaglia F, Nolsoe C, Dietrich CF et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall in Med 2012; 33: 33-59
10 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med 2013; 34: 11-29
11 Dietrich CF, Rudd L. The EFSUMB website, a guide for better understanding. Med Ultrason 2013; 15: 215-223
12 Chiorean L, Cui XW, Tannapfel A et al. Benign liver tumours in pediatric patients. Review with emphasis on imaging features. World J Gastroenterol 2015; in press
13 Wastl D, Helwig K, Dietrich CF. Examination concepts and procedures in emergency ultrasonography. Med Klin Intensivmed Notfmed 2015; 110: 231-242
14 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210
15 Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall in Med 2008; 29: 28-44
16 Dietrich CF, Sharma M, Gibson RN et al. Fortuitously discovered liver lesions. World J Gastroenterol 2013; 19: 3173-3188
17 Nolsoe C, Piscaglia F, Dietrich CF et al. Primum non nocere? Why Can't We Use Second Generation Ultrasound Contrast Agents for the Examination of Children?. Ultraschall in Med 2011; 32: 83-86
18 Dietrich CF, Mäurer M, Riemer-Hommel P. Challenges for the German Health Care System. Pharmaceuticals. Endo heute 2014; 27: 45-53
19 Dietrich CF, Riemer-Hommel P. Challenges for the German Health Care System. Z Gastroenterol 2012; 50: 557-572
20 Jacob J, Deganello A, Sellars ME et al. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall in Med 2013; 34: 529-540
21 Masetti R, Zama D, Gasperini P et al. Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. Pediatr Transplant 2013; 17: 479-486
22 Yusuf GT, Sellars ME, Huang DY et al. Cortical necrosis secondary to trauma in a child: contrast-enhanced ultrasound comparable to magnetic resonance imaging. Pediatr Radiol 2014; 44: 484-487
23 Sellars ME, Deganello A, Sidhu PS. Paediatric contrast-enhanced ultrasound (CEUS): a technique that requires co-operation for rapid implementation into clinical practice. Ultraschall in Med 2014; 35: 203-206
24 Dietrich CF, Jenssen C. Focal liver lesion, incidental finding. Dtsch Med Wochenschr 2012; 137: 2099-2116
25 Chiorean L, Cantisani V, Jenssen C et al. Focal masses in a non-cirrhotic liver: The additional benefit of CEUS over baseline imaging. Eur J Radiol 2015; 84: 1636-1643
26 Dietrich CF, Ignee A, Trojan J et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53: 401-405
27 Dietrich CF, Kratzer W, Strobe D et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705
28 Dietrich CF, Cui XW, Chiorean L et al. Local ablative procedures of the liver. Z Gastroenterol 2015; 53: 579-590
29 Trojan J, Hammerstingl R, Engels K et al. Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors. J Clin Ultrasound 2010; 38: 227-231
30 Dietrich CF, Schuessler G, Trojan J et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78: 704-707
31 Dietrich CF, Mertens JC, Braden B et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007; 45: 1139-1145
32 Ignee A, Piscaglia F, Ott M et al. A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma. Scand J Gastroenterol 2009; 44: 633-636
33 Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol 1983; 14: 512-537
34 Deutsches Kinderkrebsregister Mainz. Jahresbericht 2009. Internet Communication 01.07.2015
35 Bosman FT, Carneiro F, Hruban RH et al. Tumours of the liver and intrahepatic bile ducts. In: Bosman FT, Carneiro F, Hruban RH, et al. editors. WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer (IARC); 2010: 195-254
36 Lopez-Terrada D, Alaggio R, de Davila MT et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 2014; 27: 472-491
37 Finegold MJ. Liver tumours. In: Cullinane CJ, Burchill SA, Squire JA, et al. editors Molecular biology and pathology of paediatric cancer. Oxford University Press: 2003: 264-298
38 Dietrich CF. Liver tumor characterization – comments and illustrations regarding guidelines. Ultraschall in Med 2012; 33: S22-S30
39 Dietrich CF, Cui XW, Schreiber-Dietrich DG et al. EFSUMB guidelines 2011: comments and illustrations. Ultraschall in Med 2012; 33: S11-S21
40 Zhu XL, Chen P, Guo H et al. Contrast-enhanced ultrasound for the diagnosis of hepatic adenoma. J Int Med Res 2011; 39: 920-928
41 Manichon AF, Bancel B, Durieux-Millon M et al. Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. HPB Surg 2012; 2012: 418745
42 Anthony PP. Tumors and tumor-like lesions of the liver and biliary tract. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. Churchill Livingstone; 1994: 635-711
43 Ishak K, Goodman ZD, Stocker JT. From the archives of the AFIP (Fascicle 31): Tumors of the liver and intrahepatic bile ducts. In: From the archives of the AFIP, editor Atlas of tumor pathology. 2000: 1-185
44 Dietrich CF, Ignee A, Greis C et al. Artifacts and pitfalls in contrast-enhanced ultrasound of the liver. Ultraschall in Med 2014; 35: 108-125
45 Schnater JM, Kohler SE, Lamers WH et al. Where do we stand with hepatoblastoma? A review. Cancer 2003; 98: 668-678
46 Stocker JT. Hepatic tumors in children. In: Suchy FJ, Sokol RJ, Balistreri WF, editors Liver disease in children. Cambridge: Cambridge University Press; 2007
47 Weinberg AG, Finegold MJ. Primary hepatic tumors in childhood. In: Finegold M, editor. Pathology of neoplasia in children and adolescents. Philadelphia: W. B. Saunders; 1986: 347-348
48 Wang LL, Filippi RZ, Zurakowski D et al. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. Am J Surg Pathol 2010; 34: 287-299
49 Heck JE, Meyers TJ, Lombardi C et al. Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol 2013; 37: 390-395
50 Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 2012; 57: 930-932
51 Dietrich CF, Cui XW, Barreiros AP et al. EFSUMB guidelines 2011: comment on emergent indications and visions. Ultraschall in Med 2012; 33: S39-S47
52 Litten JB, Tomlinson GE. Liver tumors in children. Oncologist 2008; 13: 812-820
53 Czauderna P, MacKinlay G, Perilongo G et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002; 20: 2798-2804
54 Weeda VB, Murawski M, McCabe AJ et al. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience. Eur J Cancer 2013; 49: 2698-2704
55 Yang H, Liu GJ, Lu MD et al. Evaluation of the vascular architecture of hepatocellular carcinoma by micro flow imaging: pathologic correlation. J Ultrasound Med 2007; 26: 461-467
56 Stocker JT. Hepatic tumors in children. Clin Liver Dis 2001; 5: 259-281
57 Francis B, Hallam L, Kecskes Z et al. Placental mesenchymal dysplasia associated with hepatic mesenchymal hamartoma in the newborn. Pediatr Dev Pathol 2007; 10: 50-54
58 Stocker JT, Ishak KG. Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Pediatr Pathol 1983; 1: 245-267
59 Shintaku M, Watanabe K. Mesenchymal hamartoma of the liver: A proliferative lesion of possible hepatic stellate cell (Ito cell) origin. Pathol Res Pract 2010; 206: 532-536
60 Stocker JT. An approach to handling pediatric liver tumors. Am J Clin Pathol 1998; 109: S67-S72
61 Leuschner I, Schmidt D, Harms D. Undifferentiated sarcoma of the liver in childhood: morphology, flow cytometry, and literature review. Hum Pathol 1990; 21: 68-76
62 Mathews J, Duncavage EJ, Pfeifer JD. Characterization of translocations in mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver. Exp Mol Pathol 2013; 95: 319-324
63 Kordes U, Gesk S, Fruhwald MC et al. Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosomes Cancer 2010; 49: 176-181
64 Bourdeaut F, Lequin D, Brugieres L et al. Frequent hSNF5 / INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 2011; 17: 31-38
65 Mo JQ, Dimashkieh HH, Bove KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 2004; 35: 200-209
66 Cui XW, Ignee A, Woenckhaus M et al. Hämangioendotheliom, eine bildgebende Herausforderung. Endo heute 2014; 27: 34-36
67 Selby DM, Stocker JT, Ishak KG. Angiosarcoma of the liver in childhood: a clinicopathologic and follow-up study of 10 cases. Pediatr Pathol 1992; 12: 485-498
68 Dimashkieh HH, Mo JQ, Wyatt-Ashmead J et al. Pediatric hepatic angiosarcoma: case report and review of the literature. Pediatr Dev Pathol 2004; 7: 527-532
69 Strate SM, Rutledge JC, Weinberg AG. Delayed development of angiosarcoma in multinodular infantile hepatic hemangioendothelioma. Arch Pathol Lab Med 1984; 108: 943-944
70 Dietrich CF, Schreiber-Dietrich D, Hocke M. Comments on the EFSUMB non-liver Guidelines 2011. (Bern 1994): Praxis; 2012 101. 1175-1181
71 Dietrich CF, Cui XW, Boozari B et al. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines. Ultraschall in Med 2012; 33: S57-S66
72 Barreiros AP, Chiorean L, Braden B et al. Ultrasound in rare diffuse liver disease. Z Gastroenterol 2014; 52: 1247-1256
73 Brenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-2284
74 Hricak H, Brenner DJ, Adelstein SJ et al. Managing radiation use in medical imaging: a multifaceted challenge. Radiology 2011; 258: 889-905
75 Yekeler E. Pediatric abdominal applications of multidetector-row CT. Eur J Radiol 2004; 52: 31-43
76 Miglioretti DL, Johnson E, Williams A et al. The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr 2013; 167: 700-707
77 Smith-Bindman R, Miglioretti DL, Johnson E et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. JAMA 2012; 307: 2400-2409